Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing SHANGHAI and YANGZHOU, China, Jan. 7, 2025 /PRNewswire/ — Alebund Pharmaceuticals ("Alebund" or… CISION PRNewswireJanuary 7, 2025
Press ReleaseSegway Officially Recognized as Global No.1 Brand in eKickScooter Sales Micromobility leader announces verified milestone as it debuts new models during CES… CISION PRNewswireJanuary 7, 2025
Press ReleasePudu Robotics and Burroughs Forge New Partnership to Strengthen Customer-Centric Service Across North America CHICAGO, Jan. 7, 2025 /PRNewswire/ — Pudu Robotics, a global leader in service… CISION PRNewswireJanuary 7, 2025
Press ReleaseSurplusGLOBAL Appoints Stanley Choi as New CEO of Subsidiary EQ GLOBAL, Strengthening Global Semiconductor Competitiveness SEOUL, South Korea, Jan. 7, 2025 /PRNewswire/ — SurplusGLOBAL, a leading platform… CISION PRNewswireJanuary 7, 2025
Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma Verismo will receive up to $4.05 million USD in investments from the… CISION PRNewswireJanuary 7, 2025
Press ReleaseMega Matrix Inc. Attended China-UAE Industry and Investment Cooperation Conference to Further Deepen Middle East Short Drama Strategy SINGAPORE, Jan. 7, 2025 /PRNewswire/ — Mega Matrix Inc. (NYSE American: MPU) announced… CISION PRNewswireJanuary 7, 2025
Press ReleaseConcept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment TAMPA, Fla., Jan. 7, 2025 /PRNewswire/ — Concept Medical Inc., a global… CISION PRNewswireJanuary 7, 2025
Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens HONG KONG, Jan. 7, 2025 /PRNewswire/ — Eyebright Medical Technology (Beijing) Co.,… CISION PRNewswireJanuary 7, 2025
